Prelude Capital Management, LLC Qiagen N.V. Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $684,379 - $843,677	-16,733 Reduced 73.03%	6,180 $255,000
Q2 2022 Aug 15, 2022	BUY	$42.98 - $49.77 $984,800 - $1.14 Million	22,913 New	22,913 $1.08 Million
Q1 2022 May 16, 2022	SELL	$42.23 - $54.3 $221,454 - $284,749	-5,244 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$50.62 - $56.47 $265,451 - $296,128	5,244 New	5,244 $291,000
Q2 2021 Aug 16, 2021	SELL	$46.28 - $52.75 $272,635 - $310,750	-5,891 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$46.25 - $56.02 $272,458 - $330,013	5,891 New	5,891 $287,000
Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $5,853 - $6,951	-127 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$42.51 - $52.42 $303,181 - $373,859	-7,132 Reduced 98.25%	127 $7,000
Q2 2020 Aug 14, 2020	SELL	$39.49 - $44.36 $676,305 - $759,709	-17,126 Reduced 70.23%	7,259 $311,000
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $619,622 - $1.05 Million	24,385 New	24,385 $824,000
Q4 2017 Feb 14, 2018	SELL	$30.68 - $35.37 $272,223 - $313,838	-8,873 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $275,240 - $292,276	8,873	8,873 $279,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.